# EDGAR Filing Document

**Accession Number:** 0001579214
**File Stem:** 0001193125-25-178500
**Filing Date:** 2025-8
**Character Count:** 14755
**Document Hash:** 47f86c018aacd16ebaf8ad21f756bd6c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-178500.hdr.sgml**: 20250812

**ACCESSION NUMBER**: 0001193125-25-178500

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20250808

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250812

**DATE AS OF CHANGE**: 20250812

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Emerald Holding, Inc.
- **CENTRAL INDEX KEY:** 0001579214
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-BUSINESS SERVICES, NEC [7389]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 421775077
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38076
- **FILM NUMBER:** 251204127

**BUSINESS ADDRESS:**
- **STREET 1:** 31910 DEL OBISPO STREET
- **STREET 2:** SUITE 200
- **CITY:** SAN JUAN CAPISTRANO
- **STATE:** CA
- **ZIP:** 92675
- **BUSINESS PHONE:** 949-226-5700

**MAIL ADDRESS:**
- **STREET 1:** 31910 DEL OBISPO STREET
- **STREET 2:** SUITE 200
- **CITY:** SAN JUAN CAPISTRANO
- **STATE:** CA
- **ZIP:** 92675

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Emerald Expositions Events, Inc.
- **DATE OF NAME CHANGE:** 20170330

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Expo Event Holdco, Inc.
- **DATE OF NAME CHANGE:** 20130613

?xml version='1.0' encoding='ASCII'? 8-K

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549**

------

## **FORM** 8-K

------

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported):** August 08, 2025<br>

------

Emerald Holding, Inc.

**(Exact name of Registrant as Specified in Its Charter)**

------

---

| | | |
|:---|:---|:---|
| Delaware | 001-38076 | 42-1775077 |
| **(State or Other Jurisdiction<br>of Incorporation)** | **(Commission File Number)** | **(IRS Employer<br>Identification No.)** |
| 100 Broadway, 14th Floor |  |  |
| New York**,** New York |  | 10005 |
| **(Address of Principal Executive Offices)** |  | **(Zip Code)** |

---

**Registrant's Telephone Number, Including Area Code:** (949) 226-5700<br>

**(Former Name or Former Address, if Changed Since Last Report)**

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **<br>Title of each class** | **Trading<br>Symbol(s)** | **<br>Name of each exchange on which registered** |
| Common Stock, par value $0.01 per share | EEX | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

## **Item 7.01 Regulation FD Disclosure.** 
On August 8, 2025, Emerald Holding, Inc. (the "Company") through its wholly-owned subsidiary, 17208227 Canada Inc. ("Emerald Canada"), entered into a share purchase agreement with Generis Global Partners Corp. ("Generis Global"), its shareholders and Generis Global Partners Europe GmbH ("Generis Europe" and together with Generis Global, the "Generis Group"), pursuant to which Emerald Canada acquired all of the outstanding share capital of the Generis Group. The purchase price consideration of the transaction was approximately $60.0 million plus future contingent payments based on business performance.

A copy of the press release is attached to this report as Exhibit 99.1. The information furnished pursuant to Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except as expressly set forth by specific reference in such filing.

## **Item 9.01 Financial Statements and Exhibits.** 
(d) Exhibits.

Exhibit No. Description <br> 99.1 104 [<u>Press Release of the Company.</u>](eex-ex99_1.htm)Cover Page Interactive Data File (embedded within the inline XBRL document)

##  **<u>Cautionary Note Regarding Forward-Looking Statements</u>** 
The information set forth and incorporated by reference in this Current Report on Form 8-K contains certain forward-looking statements regarding the Company and its subsidiaries, including, without limitation, statements regarding our ability to return our business to pre-COVID levels; general economic conditions, or more specifically about the markets in which we operate, including growth of our various markets, and our expectations, beliefs, plans, strategies, objectives, prospects, assumptions or future events or performance; the multiple avenues to return to organic growth; expectations regarding interest rates and economic conditions, among others; our guidance with respect to estimated revenues and Adjusted EBITDA; our ability or inability to obtain insurance coverage relating to event cancellations or interruptions; our intention to continue to pay regular quarterly dividends; our ability to successfully identify and acquire acquisition targets; our expectations arising from the ongoing impact of natural disasters, or outbreaks of contagious disease or the potential for infection (including COVID-19) on our business; how we integrate and grow acquired businesses; and how we expand our international operations, among others. In particular, the declaration, timing and amount of any future dividends will be subject to the discretion and approval of the Company's Board of Directors, and will depend on a number of factors. The forward-looking statements contained or incorporated by reference herein are based on management's current expectations as well as estimates and assumptions prepared by management as of the date hereof, and although they are believed to be reasonable, they are inherently uncertain and not guaranteed. These statements involve risks and uncertainties outside of the Company's control that may cause actual results, performance, or achievements to differ materially, and there can be no assurance that the projected results and forward-looking statements included or incorporated by reference herein will prove to be accurate. In addition, even if the Company's results of operations, financial condition and liquidity, and events in the industry in which it operates, are consistent with the forward-looking statements contained or incorporated by reference herein, they may not be predictive of results or developments in future periods. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Forward looking statements include all statements that are not historical facts and can be identified by terms such as "anticipate," "believe, "continue," "could," "estimate," "expect," "intend," "may," "might," "objective," "ongoing," "plan," "potential," "predict," "project," "seek," "should," "target," "will," or "would" or similar expressions and the negatives of those terms. For factors that could cause actual results to differ materially from the forward-looking statements included or incorporated by reference herein, please see the risks and uncertainties identified under the headings "Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements" in the Company's most recently filed annual report on Form 10-K for the year ended December 31, 2024, which is available on the Company's Investor Relations website at investor.emeraldx.com and on the SEC's EDGAR website at www.sec.gov. The Company disclaims any obligation to update or revise any of the forward-looking statements contained or incorporated by reference herein, whether as a result of new information, future events or otherwise. Past results are not indicative of future performance.

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  |  |  | **EMERALD HOLDING, INC.** |
| Date: | August 12, 2025 | By:  | /s/ David Doft |
|  |  |  | David Doft<br>Chief Financial Officer |

---

------

## Exhibit 99.1

**Exhibit 99.1**

**Emerald Acquires Generis Group, Accelerating Growth in Executive-Level Summits**

*Acquisition Adds Proven, Insight-Led Events That Build on Emerald's High-Impact Executive Summits*

New York, NY, August 12, 2025 – Emerald Holding, Inc. (NYSE: EEX) ("Emerald") today announced that it has acquired 100% of the equity interest in Generis Group ("Generis"), a Toronto-based leader in B2B executive summits, enabling high-impact peer-to-peer connections. The acquisition enhances Emerald's existing portfolio of proven executive-level summits by adding Generis' insight-led, one-to-one meeting formats, known for delivering exceptional customer satisfaction and measurable business impact, in key growth markets.

"This acquisition is a strategic step in expanding Emerald's presence in delivering proven, executive-level experiences across the U.S. and Europe," said Hervé Sedky, CEO and President of Emerald. "These formats consistently deliver the highest satisfaction scores in our event portfolio and represent a key growth engine for the business. With the addition of Generis, Emerald will now host more than 50 executive summits annually - underscoring the strength, scale, and value of our offering. Together, we're unlocking new opportunities to deepen executive relationships and drive sustained, long-term growth."

Founded in 2014 by Francesco Scalzo, Jason Cheddie, and Nadim Allidina, Generis has established itself as a leader in high-impact, peer-to-peer executive summits – hosting eleven annual events across the U.S. and six in Europe. The company engages senior leaders across key verticals, including supply chain, manufacturing, packaging, digital transformation, and life sciences. Each Summit delivers targeted content and meaningful connections that support strategic decision-making and business growth. Generis' curated events are built around the priorities of senior executives, featuring expert-led panels, curated content, and a proprietary one-to-one matchmaking platform that drives alignment and measurable outcomes. Generis' differentiated model, anchored in personalized engagement and premium sponsor integration, has fueled consistent growth and strong customer retention.

"We are incredibly proud of what Generis has achieved over the past decade," said Francesco Scalzo, CEO of Generis. "We believe Emerald's expertise will empower Generis to scale our impact even more rapidly and reach new heights, while staying true to what has made our events valuable to senior executives. Together, we'll redefine what exceptional looks like in the executive summits space."

"This milestone is a reflection of the extraordinary commitment of our team and the enduring value of authentic connection in business," said Jason Cheddie, COO of Generis. "From the beginning, we built Generis with a clear focus on people - our colleagues, our clients, and the executive communities we serve. Partnering with Emerald gives us the platform to scale that vision, deepen our impact, and continue delivering experiences that are thoughtful, effective, and grounded in purpose. We are excited for what lies ahead."

------

**Forward-Looking Statements** 

This press release contains certain forward-looking statements regarding Emerald and its subsidiaries (collectively, the "Company"). All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding the Company's ability to integrate and grow acquired businesses. These statements are based on management's current expectations as well as estimates and assumptions prepared by management as of the date hereof, and although they are believed to be reasonable, they are inherently uncertain and not guaranteed. These statements involve risks and uncertainties, including, but not limited to, economic, competitive, governmental and technological factors outside of the Company's control that may cause its business, industry, strategy, financing activities or actual results to differ materially. See "Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements" in the Company's most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company undertakes no obligation to update or revise any of the forward-looking statements contained herein, whether as a result of new information, future events or otherwise. Past results are not indicative of future performance.

**About Emerald**

**About Generis Group**

Generis Group is an award-winning, full-service B2B event organizer committed to empowering executives worldwide to network, learn, and thrive through a dynamic portfolio of industry-leading summits. With expertise spanning aerospace and defense, automotive, food and beverage, packaging, pharma and biopharma, supply chain, manufacturing, medical devices, and information technology and cybersecurity, Generis Group fosters innovation, collaboration, and strategic growth across the globe. Discover more at www.generisgp.com.

![img201606797_0.gif](img201606797_0.gif)**Emerald Holding, Inc.** <br>Investor Relations<br>investor.relations@emeraldx.com<br>1-866-339-4688 (866EEXINVT)

Source: Emerald Holding, Inc.

------